.png)
Munich, Germany & Tartu, Estonia, November 24, 2025 — Missed incidental cancers remain one of radiology’s hidden challenges. Many kidney cancers are first visible on CT scans taken for unrelated conditions, yet escape attention. deepc and Better Medicine are now addressing this issue together through a clinically validated AI solution built to support radiologists where it matters most.
Supporting radiologists in everyday practice
Better Medicine’s BMVision Kidney assists radiologists during contrast-enhanced CT exams by detecting and prioritising incidental kidney cancers and suspicious lesions that might fall outside the main diagnostic focus. It functions as both a safety net and a triage tool, helping ensure that important findings are not missed.
Radiologists using BMVision Kidney can detect, measure, and report kidney lesions up to 52% faster, achieving 99.2% sensitivity with AI assistance. Faster detection and reporting frees radiologists to apply their expertise where it has the greatest clinical impact and enables hospitals to run radiology departments with greater precision and flow. By highlighting hidden lesions early, the solution also supports faster patient referral and more timely intervention.
Expanding access through deepcOS®
Through its integration on deepcOS®, BMVision Kidney is now accessible within a secure and vendor-neutral environment that enables hospitals to deploy trusted AI solutions seamlessly. The collaboration connects Better Medicine’s clinically proven diagnostic technology with deepc’s established infrastructure, ensuring that validated AI tools fit directly into existing workflows. Each new integration on deepcOS® expands the ecosystem of clinically proven AI available to radiology teams globally, supporting scalable and evidence-based innovation.
Advancing meaningful use of AI in radiology
The partnership reflects a shared mission to make AI clinically relevant and operationally ready for radiology teams. By combining validated algorithms with real-world integration, deepc and Better Medicine enable healthcare institutions to enhance diagnostic accuracy and patient safety while maintaining full control of their data. deepc notes that integrating clinically validated AI such as BMVision Kidney supports its broader goal of enabling practical, secure, and meaningful AI adoption across healthcare institutions.
Organisations aiming to strengthen early detection in abdominal imaging can now access Better Medicine’s BMVision Kidney through deepcOS®.
About deepc
deepc enables the infrastructure layer that powers safe, vendor-neutral AI in medical imaging. Our platform, deepcOS®, spans the full product lifecycle: discovery, clinical validation, deployment, monitoring, and governance, so hospitals can adopt, scale, and continuously improve the AI tools that matter most to their workflows. Through rigorous, large-scale testing on independent and local data sets, deepc certifies every integrated algorithm for performance, robustness, and regulatory compliance. Clinicians can then easily activate best-in-class solutions across more than 80 indications, confident that patient safety and data privacy are protected by design. deepcOS® installs quickly and interfaces seamlessly with existing PACS/RIS, cloud, or on-prem environments. By abstracting complexity and preserving choice, deepc empowers radiology departments to build and evolve an AI-driven practice—faster, safer, and on their own terms today and into the future.
About Better Medicine
‘Enhancing Patient Outcomes in Radiology Workflows with Intelligent Insights’ Better Medicine are redefining oncology diagnostics in medical imaging utilising AI solutions to enhance the detection and segmentation of lesions throughout the entire body with a key focus on incidental findings of suspicious lesions from routine CT scans, supported by semi-automated lesion segmentation solutions.
